Parkinson Disease: review
Article Sidebar
Main Article Content
Abstract
Parkinson’s sickness (PD) is a neurodegenerative ailment precipitated by the death of a kind of neuron that plays an integral function in the production of dopamine in the brain. The pathophysiology of this sickness is based totally on the formation of alpha syncline folds that generate Lewy bodies, which are cytotoxic and minimize dopamine levels. Most pharmacological redress for PD goal alphasynuclein to limit the symptoms. However, the therapeutic method to this pathology includes combination of pharmacological and non-pharmacological strategies to maximize results and improve symptomatological manipulate in these patients. It is therefore essential to delve deeper into the pathophysiology of the ailment in order to enhance these remedies and consequently the exceptional of life of the patients. Therefore, we urgently want to analyze every cutting-edge clinical trial’s status and therapeutic approach to find out new therapeutic tactics for PD treatment. We hope this evaluate can supply new ideas and insights for PD remedy development.
Article Details
References
Charles H. Adler and Thomas G. Beach. “Neuropathological Basis of Nonmotor Manifestations of Parkinson’s Disease”. eng. In: Movement Disorders: Official Journal of the Movement Disorder Society 31.8 (Aug. 2016), pp. 1114–1119. issn:1531-8257.
Hubert M. Fonteijn et al. “An Event-Based Disease Progression Model and Its Application to Familial Alzheimer’s Disease”. eng. In: Information Processing in Medical Imaging: Proceedings of the ... Conference 22 (2011), pp. 748–759.
Julia C. Greenland, Caroline H. Williams-Gray, and Roger A. Barker. “The Clinical Heterogeneity of Parkinson’s Disease and Its Therapeutic Implications”. eng. In: The European Journal of Neuroscience 49.3 (Feb. 2019), pp. 328–338.
Philipp Mahlknecht, Klaus Seppi, and Werner Poewe. “The concept of prodromal Parkinson’s disease”. In: Journal of Parkinson’s disease 5.4 (2015), pp. 681–697.
Fausto Milletari, Nassir Navab, and Seyed-Ahmad Ahmadi. “V-net: Fully convolutional neural networks for volumetric medical image segmentation”. In: 2016 fourth international conference on 3D vision (3DV). IEEE. 2016, pp. 565–571.
Jean-Baptiste Schiratti. “Methods and Algorithms to Learn Spatio-Temporal Changes from Longitudinal Manifold-Valued Observations”. These de Doctorat. Université Paris-Saclay (ComUE), Jan. 2017.
Friederike Sixel-Döring et al. “Associated factors for REM sleep behavior disorder in Parkinson disease”. In: Neurology 77.11 (2011), pp. 1048–1054.
Liu, C.; Yang, Y.; Rakstys, K.; Mahata, A.; Franckevicius, M.; Mosconi, E.; Skackauskaite, R.; Ding, B.; Brooks, K.G.; Usiobo, O.J.;et al. Tuning Structural Isomers of Phenylenediammonium to Afford Efficient and Stable Perovskite Solar Cells and Modules. Nat. Commun. 2021, 12, 6394.
Sabbagh, A.; Beccaria, K.; Ling, X.; Marisetty, A.; Ott, M.; Caruso, H.; Barton, E.; Kong, L.-Y.; Fang, D.; Latha, K.; et al. Opening of the Blood-Brain Barrier Using Low-Intensity Pulsed Ultrasound Enhances Responses to Immunotherapy in Preclinical Glioma Models. Clin. Cancer Res. 2021, 27, 4325–4337.
Zhao, Y.; Gan, L.; Ren, L.; Lin, Y.; Ma, C.; Lin, X. Factors Influencing the Blood-Brain Barrier Permeability. Brain Res. 2022, 1788, 147937.
Singh, A.; Tripathi, P.; Yadawa, A.K.; Singh, S. Promising Polyphenols in Parkinson’s Disease Therapeutics. Neurochem. Res. 2020, 45, 1731–1745.
NHS NATIONAl for health and clinical excellence.